methylnitrosourea has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul Jalal, MI; Al-Astani Tengku Din, TA; Ariffin Wan Mansor, WN; Idris, FM; Jaafar, H; Shamsuddin, SH | 1 |
| Jaafar, H; Jaffar, NFN; Muhammad Sakri, MS; Tengku Din, TADA; Wan Abdul Rahman, WF | 1 |
2 other study(ies) available for methylnitrosourea and sirolimus
| Article | Year |
|---|---|
Rapamycin and PF4 induce apoptosis by upregulating Bax and down-regulating survivin in MNU-induced breast cancer.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Transformation, Neoplastic; Down-Regulation; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Microtubule-Associated Proteins; Platelet Factor 4; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirolimus; Survivin; Transcriptional Activation; Up-Regulation | 2014 |
Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sirolimus; Sunitinib | 2020 |